Press Releases

Filters
October 16, 2006

Debiopharm and Cambridge Antibody Technology enter into an exclusive agreement to develop and market SC-1 for gastric carcinomas

Read more
October 11, 2006

Debiopharm and EPFL honour Dr Eduard Batlle with the “Debiopharm Life Sciences Award”

Read more
October 2, 2006

The Japanese Cancer Association (JCA) and Debiopharm honour Professors Masanori Hatakeyama and Johji Inazawa with the 2006 JCA-Mauvernay Award

Read more
September 21, 2006

Debiopharm granted European Orphan Drugs Status for Debio-0513 (PTR-262) for Myasthenia Gravis

Read more
September 5, 2006

Debiopharm and Salix pharmaceuticals sign license agreement for Sanvar®

Read more
July 24, 2006

Debiopharm applies for first europe marketing authorisation for Sanvar® in France

Read more
June 27, 2006

Debiopharm and Aurigene enter into an Agreement to identify and develop selective compounds for immuno-oncology targets

Read more
June 20, 2006

Moapar® 3-months approved for the lowering of testosterone to castrate serum levels for control of sexual drive in adult men

Read more
June 14, 2006

The Debiopharm Group and Sigma-Tau sign R&D and commercial agreement for Istaroxime in acute heart failure syndromes

Read more